Incyte (INCY) EVP sells 3,074 shares at $94.02; 29,241 left
Incyte Corp (INCY) reported an insider transaction on Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Incyte Corp (INCY) reported an insider transaction on Form 4. The company’s EVP, Head of Incyte Intl, sold 3,074 shares of common stock on 11/03/2025 at $94.02 per share.
Following the sale, the reporting person beneficially owned 29,241 shares directly. This figure includes 26,167 shares issuable pursuant to previously reported RSUs that have not vested.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,074 | $94.02 | $289K |
Footnotes (1)
- F1. This includes an aggregate of 26,167 shares of common stock issuable pursuant to previously reported RSUs that have not vested.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Incyte (INCY) disclose in this Form 4?
Who is the reporting person in the INCY Form 4?
Were restricted stock units (RSUs) mentioned?
What was the transaction code for the sale?
Was the filing made by one person or a group?
What is the ownership form after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.